Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis

Joep de Bruijne; Jilling F. Bergmann; Christine J. Weegink; Richard Molenkamp; Janke Schinkel; Michelle A. Treitel; Eric A. Hughes; Andre A. van Vliet; Robert J. de Knegt; Hendrik W. Reesink; Harry L. Janssen

Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis

Joep de Bruijne
, Jilling F. Bergmann
, Christine J. Weegink
, Richard Molenkamp
, Janke Schinkel
, Michelle A. Treitel
, Eric A. Hughes
, Andre A. van Vliet
, Robert J. de Knegt
, Hendrik W. Reesink
, Harry L. Janssen

Gastroenterology & Hepatology

Amsterdam UMC
University of Amsterdam
Merck & Company

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Original language	English
Pages (from-to)	1019A-1020A
Number of pages	2
Journal	Hepatology
Volume	50
Issue number	4
Publication status	Published - Oct 2009
Event	60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases - Boston, Morocco Duration: 30 Oct 2009 → 3 Nov 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

de Bruijne, J., Bergmann, J. F., Weegink, C. J., Molenkamp, R., Schinkel, J., Treitel, M. A., Hughes, E. A., van Vliet, A. A., de Knegt, R. J., Reesink, H. W., & Janssen, H. L. (2009). Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis. Hepatology, 50(4), 1019A-1020A.

@article{821577faf02044de9ca6e982776a0cc3,

title = "Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis",

author = "\{de Bruijne\}, Joep and Bergmann, \{Jilling F.\} and Weegink, \{Christine J.\} and Richard Molenkamp and Janke Schinkel and Treitel, \{Michelle A.\} and Hughes, \{Eric A.\} and \{van Vliet\}, \{Andre A.\} and \{de Knegt\}, \{Robert J.\} and Reesink, \{Hendrik W.\} and Janssen, \{Harry L.\}",

year = "2009",

month = oct,

language = "English",

volume = "50",

pages = "1019A--1020A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams \& Wilkins",

number = "4",

note = "60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases ; Conference date: 30-10-2009 Through 03-11-2009",

}

de Bruijne, J, Bergmann, JF, Weegink, CJ, Molenkamp, R, Schinkel, J, Treitel, MA, Hughes, EA, van Vliet, AA, de Knegt, RJ, Reesink, HW & Janssen, HL 2009, 'Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis', Hepatology, vol. 50, no. 4, pp. 1019A-1020A.

Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis. / de Bruijne, Joep; Bergmann, Jilling F.; Weegink, Christine J. et al.
In: Hepatology, Vol. 50, No. 4, 10.2009, p. 1019A-1020A.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks

T2 - 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

AU - de Bruijne, Joep

AU - Bergmann, Jilling F.

AU - Weegink, Christine J.

AU - Molenkamp, Richard

AU - Schinkel, Janke

AU - Treitel, Michelle A.

AU - Hughes, Eric A.

AU - van Vliet, Andre A.

AU - de Knegt, Robert J.

AU - Reesink, Hendrik W.

AU - Janssen, Harry L.

PY - 2009/10

Y1 - 2009/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000270456001550&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0270-9139

VL - 50

SP - 1019A-1020A

JO - Hepatology

JF - Hepatology

IS - 4

Y2 - 30 October 2009 through 3 November 2009

ER -

Svr Results in Chronic Hepatitis C Genotype 1 Patients Dosed with Sch 900518 and Peginterferon Alfa-213 for 2 Weeks, Followed By Peginterferon Alfa-213 and Ribavirin for 24/48 Weeks: An Interim Analysis

UN SDGs

Other files and links

Cite this